Skip to main content

Table 4 Differences in immune-activation markers between men and women

From: Sex-related differences in markers of immune activation in virologically suppressed HIV-infected patients

 MarkersMen
[MRD ± sigma]
Women
[MRD ± sigma]
p-value
CD4+CD4+0.03 ± 0.090.11 ± 0.060.07
CD4+ 38+0.11 ± 0.10-2.29 ± 0.970.024†
CD4+ 38+DR+0.47 ± 0.100.36 ± 0.130.053
CD4+ DR+0.19 ± 0.16-0.37 ± 0.830.052
CD4+ NAÏVE-6.38 ± 1.19-5.36 ± 1.240.072
CD4+ NAÏVE CD38+0.05 ± 0.35-1.28 ± 0.210.044†
CD4+ NAÏVE0.35 ± 0.301.62 ± 0.090.044†
CD38+DR+1.61 ± 0.06-0.61 ± 0.060.010†
CD4+ NAÏVE DR+0.40 ± 0.060.45 ± 0.050.487
CD4+ TCM-0.19 ± 0.14-1.72 ± 1.490.324
CD4+ TCM 38+0.16 ± 0.20-6.23 ± 1.590.035†
CD4+ TCM 38+DR+0.72 ± 1.17-0.19 ± 0.120.047†
CD4+ TCM DR+0.01 ± 0.18-0.19 ± 0.240.523
CD4+ TEM0.28 ± 0.19-5.86 ± 1.110.033†
CD4+ TEM 38+-1.23 ± 0.55-0.32 ± 0.810.370
CD4+ TEM 38+DR+-1.40 ± 0.520.31 ± 0.110.007†
CD4+ TEM DR+-0.15 ± 0.08-0.38 ± 0.110.094
CD8+0.23 ± 0.17-4.22 ± 0.840.027†
CD8+CD8+ 38+-0.21 ± 0.24-0.86 ± 1.190.060
CD8+ 38+DR+-0.16 ± 0.230.59 ± 0.080.010†
CD8+ DR+-4.05 ± 1.51-1.06 ± 0.740.010†
CD8+ NAÏVE-0.56 ± 0.34-8.14 ± 1.640.024†
CD8+ NAÏVE CD38+-0.29 ± 0.61-6.21 ± 2.910.041†
CD8+ NAÏVE0.29 ± 0.080.76 ± 0.040.103
CD38+DR+0.48 ± 0.080.26 ± 0.020.243
CD8+ NAÏVE DR+0.05 ± 0.29-4.92 ± 1.090.024†
CD8+ TCM-1.55 ± 0.60-1.39 ± 1.480.923
CD8+ TCM 38+-0.05 ± 0.18-1.68 ± 1.060.044†
CD8+ TCM 38+DR+-0.29 ± 0.19-0.61 ± 0.300.081
CD8+ TCM DR+0.28 ± 0.21-7.99 ± 0.800.032†
CD8+ TEM-4.12 ± 2.490.43 ± 0.020.010†
CD8+ TEM 3-1.81 ± 0.870.06 ± 0.040.007†
  1. Columns show (1) marker name, (2) men and (3) women MRD ± sigma, and (4) p value. The statistical significance is achieved when p < 0.05. Data are expressed as mean ± sigma. Statistical differences between men and women patients were evaluated using Student’s t tests